The effect of carvedilol therapy on myocardial functional reserve in patients with advanced heart failure caused by nonischemic dilated cardiomyopathy

J Am Soc Echocardiogr. 2006 May;19(5):529-35. doi: 10.1016/j.echo.2005.12.022.

Authors

Ioannis A Paraskevaidis¹, Dimitrios Tsiapras, George Karavolias, Stamatis Adamopoulos, Thomas Dodouras, Philippos Cokkinos, Dimitrios Th Kremastinos

Affiliation

¹ Second Department of Cardiology, Onassis Cardiac Surgery Center, Athens, Greece. [email protected]

PMID: 16644436
DOI: 10.1016/j.echo.2005.12.022

No abstract available

Publication types

Controlled Clinical Trial

MeSH terms

Adult
Carbazoles / administration & dosage*
Cardiomyopathy, Dilated / complications
Cardiomyopathy, Dilated / diagnostic imaging*
Cardiomyopathy, Dilated / drug therapy*
Carvedilol
Female
Heart / drug effects
Heart Failure / diagnostic imaging*
Heart Failure / drug therapy*
Heart Failure / etiology
Humans
Male
Myocardial Ischemia / complications
Myocardial Ischemia / diagnostic imaging
Myocardial Ischemia / drug therapy
Prognosis
Propanolamines / administration & dosage*
Stroke Volume / drug effects
Treatment Outcome
Ultrasonography
Vasodilator Agents / administration & dosage
Ventricular Dysfunction, Left / diagnostic imaging*
Ventricular Dysfunction, Left / drug therapy*
Ventricular Dysfunction, Left / etiology

Substances

Carbazoles
Propanolamines
Vasodilator Agents
Carvedilol